Mental Health Engagement Network (MHEN)

Lawson Health Research Institute

Status: Completed

Conditions: Psychotic Disorder; Mood Disorder

Treatments: Behavioral: Access to TELUS Health Space and Smart Phone

Study type: Interventional

Funder types: Other

Identifiers

NCT01473550

18451

Details and patient eligibility

About

Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.

Enrollment: 400 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be diagnosed with mood disorder or psychotic disorder for a minimum one year
• Able to make informed consent to participate in the study
• Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion criteria

• Younger than 18 or older than 80

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

400 participants in 2 patient groups

Early Intervention

Experimental group

Description:

At Phase 1 (first 3 months of project), the 200 participants in Group 1 will be provided with a Personal Health Record (PHR) through TELUS Health Space, as well as they will be introduced to smart phone technology to ready them for deployment of the prompts and reminders. Two months later, they will be provided with a smart phone.

Treatment:

Behavioral: Access to TELUS Health Space and Smart Phone

Later Intervention

Experimental group

Description:

A delayed implementation plan will be used (but will have no effect on the standard of care for the remaining 200 participants), so the remaining 200 participants in Group 2 will initially act as a control group, but at Phase 2 (six months later - approximately June 2012) the remaining 200 participants will be introduced to the technology in the same order (PHR -\> Smart Phone). Group 2 will have the benefit of any enhancements made during Phase 1 of the project.

Treatment:

Behavioral: Access to TELUS Health Space and Smart Phone